scholarly journals Long term follow up of untreated primary hyperparathyroidism.

BMJ ◽  
1985 ◽  
Vol 290 (6461) ◽  
pp. 64-65 ◽  
Author(s):  
C Nagant de Deuxchaisnes ◽  
J P Devogelaer ◽  
J P Huaux
2003 ◽  
Vol 58 (3) ◽  
pp. 348-354 ◽  
Author(s):  
D. Sudhaker Rao ◽  
Elizabeth A. Wallace ◽  
Rosella F. Antonelli ◽  
Gary B. Talpos ◽  
Mohammed R. Ansari ◽  
...  

BMJ ◽  
1985 ◽  
Vol 290 (6477) ◽  
pp. 1288-1288
Author(s):  
C N. de Deuxchaisnes

Author(s):  
Mona Abouzaid ◽  
Ahmed Al-Sharefi ◽  
Satish Artham ◽  
Ibrahim Masri ◽  
Ajay Kotagiri ◽  
...  

Summary An 82-year-old male with a proven diagnosis of primary hyperparathyroidism (PHPT) was found to have bilateral changes in the fundi during a routine eye examination which were consistent with SC. In this report, we discuss the link between SC and PHPT and question the need for prospective observational studies to establish the true association between these conditions. Though screening PHPT patients for SC might not be justified/warranted given the benign course of the latter, patients with SC need to be assessed for PHPT, as the former may be the first clue to an underlying treatable systemic disease. Learning points: Sclerochoroidal calcifications (SCs), though rare and harmless, could be associated with an underlying systemic disease, such as primary hyperparathyroidism (PHPT). Biochemical screening for hypercalcaemia is a simple, cheap and widely available tool that could facilitate an identification of undiagnosed PHPT in patients with SC. A joint care by endocrinologists and ophthalmologists is warranted for those patients, as thorough investigations and long-term follow-up plans are crucial.


2014 ◽  
Vol 58 (5) ◽  
pp. 583-586 ◽  
Author(s):  
Larissa Pimentel ◽  
Sirley Portela ◽  
Alyne Loureiro ◽  
Francisco Bandeira

Normocalcemic primary hyperparathyroidism (NPHPT) is a condition characterized by elevation of the parathyroid hormone (PTH) in the presence of normal serum calcium and the absence of secondary causes. The case described illustrates the long-term follow-up of a postmenopausal woman with NPHPT patient who progressed with multiple adenomas. This case reports a 77-year-old female who has chronic generalized pain and osteoporosis. Her initial serum PTH was 105 pg/mL, with total serum calcium of 9.6 mg/dL, albumin 4.79 g/dL, phosphorus 2.8 mg/dL, and 25OHD after supplementation was 34.6 ng/mL. The bone densitometry (BMD) results were as follows: lumbar spine: T-score -3.0, femoral neck: T-score -2.6 and distal radius: -4.2. Other causes of secondary hyperparathyroidism were ruled out and cervical ultrasound and Tc-99-Sestamibi scan were negative. She used oral alendronate and three infusions of zoledronic acid for treatment of osteoporosis. In the 10th year of follow-up, after successive negative cervical imaging, ultrasound showed a nodule suggestive of an enlarged right inferior parathyroid gland. PTH levels in fluid which was obtained during fine-needle aspiration (FNA) were over 5,000 pg/mL and a Sestamibi scan was negative. The patient underwent parathyroidectomy, and a histological examination confirmed parathyroid adenoma. Post-operatively serum PTH remained elevated in the presence of normal serum calcium levels. A follow-up cervical ultrasound showed a new solid nodule suggestive of an enlarged right superior parathyroid gland. PTH levels in the aspiration fluid were remarkably high. A second parathyroidectomy was performed, with the excision of a histologically confirmed parathyroid adenoma. In conclusion, this is an unusual presentation of NPHPT and highlights the long-term complications.


BMJ ◽  
1984 ◽  
Vol 289 (6454) ◽  
pp. 1261-1263 ◽  
Author(s):  
C R Paterson ◽  
J Burns ◽  
E Mowat

Sign in / Sign up

Export Citation Format

Share Document